FDA Clears Expanded Indications for Swift Microwave Wart Device
New data show the Swift system reduces blistering, discomfort, and recovery time while maintaining strong clinical outcomes for common and plantar warts.
New data show the Swift system reduces blistering, discomfort, and recovery time while maintaining strong clinical outcomes for common and plantar warts.
Expanded clearance allows the system to support hair removal and vascular lesion treatment using multiple wavelength configurations.
The trials will investigate whether rhPDGF-BB can improve infraorbital hollowing and stimulate collagen, elastin, and other changes in facial skin.